HEADER OXIDOREDUCTASE 07-MAY-01 1IL0 TITLE X-RAY CRYSTAL STRUCTURE OF THE E170Q MUTANT OF HUMAN L-3-HYDROXYACYL- TITLE 2 COA DEHYDROGENASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-HYDROXYACYL-COA DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HCDH; COMPND 5 EC: 1.1.1.35; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HCDH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS ABORTIVE TERNARY COMPLEX, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.J.BARYCKI,L.K.O'BRIEN,A.W.STRAUSS,L.J.BANASZAK REVDAT 5 27-OCT-21 1IL0 1 REMARK SEQADV REVDAT 4 04-APR-18 1IL0 1 REMARK REVDAT 3 24-FEB-09 1IL0 1 VERSN REVDAT 2 01-APR-03 1IL0 1 JRNL REVDAT 1 07-NOV-01 1IL0 0 JRNL AUTH J.J.BARYCKI,L.K.O'BRIEN,A.W.STRAUSS,L.J.BANASZAK JRNL TITL GLUTAMATE 170 OF HUMAN L-3-HYDROXYACYL-COA DEHYDROGENASE IS JRNL TITL 2 REQUIRED FOR PROPER ORIENTATION OF THE CATALYTIC HISTIDINE JRNL TITL 3 AND STRUCTURAL INTEGRITY OF THE ENZYME. JRNL REF J.BIOL.CHEM. V. 276 36718 2001 JRNL REFN ISSN 0021-9258 JRNL PMID 11451959 JRNL DOI 10.1074/JBC.M104839200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.J.BARYCKI,L.K.O'BRIEN,A.W.STRAUSS,L.J.BANASZAK REMARK 1 TITL SEQUESTRATION OF THE ACTIVE SITE BY INTERDOMAIN SHIFTING. REMARK 1 TITL 2 CRYSTALLOGRAPHIC AND SPECTROSCOPIC EVIDENCE FOR DISTINCT REMARK 1 TITL 3 CONFORMATIONS OF L-3-HYDROXYACYL-COA DEHYDROGENASE REMARK 1 REF J.BIOL.CHEM. V. 275 27186 2000 REMARK 1 REFN ISSN 0021-9258 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 253077.140 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 35920 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1821 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5613 REMARK 3 BIN R VALUE (WORKING SET) : 0.2820 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 255 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4478 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 196 REMARK 3 SOLVENT ATOMS : 242 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.25 REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.38 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 2.380 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.660 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.050 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.910 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.550 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NAD_MOD.PARAM REMARK 3 PARAMETER FILE 4 : CAA.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NAD.TOP REMARK 3 TOPOLOGY FILE 4 : CAA.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1IL0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-MAY-01. REMARK 100 THE DEPOSITION ID IS D_1000013379. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JAN-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC MAXFLUX REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35973 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.890 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 7.96 REMARK 200 R MERGE FOR SHELL (I) : 0.26400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 9.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1F0Y REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, N-[2-ACETAMIDO]-2 REMARK 280 -IMINODIACETIC ACID, PH 6.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.82850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.19750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.85950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.19750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.82850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.85950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ACTIVE DIMER IS CONTAINED WITHIN THE REMARK 300 ASYMETRIC UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 THR A 5 REMARK 465 ALA A 6 REMARK 465 SER A 7 REMARK 465 ALA A 8 REMARK 465 SER A 9 REMARK 465 ALA A 10 REMARK 465 LYS A 11 REMARK 465 SER B 1 REMARK 465 SER B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 THR B 5 REMARK 465 ALA B 6 REMARK 465 SER B 7 REMARK 465 ALA B 8 REMARK 465 SER B 9 REMARK 465 ALA B 10 REMARK 465 LYS B 11 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 82 CG CD OE1 OE2 REMARK 470 GLU B 82 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 70 59.96 -119.90 REMARK 500 VAL A 109 134.43 -37.86 REMARK 500 ALA A 127 171.35 -59.58 REMARK 500 PHE A 205 -116.75 57.83 REMARK 500 ILE A 206 -73.67 -103.74 REMARK 500 ASP A 269 53.80 -178.98 REMARK 500 ALA A 270 -2.24 -53.92 REMARK 500 LYS B 67 4.76 -62.14 REMARK 500 LYS B 68 -30.47 -138.46 REMARK 500 GLU B 72 43.01 -105.14 REMARK 500 ASN B 73 75.43 -176.53 REMARK 500 ALA B 107 59.07 -141.89 REMARK 500 VAL B 109 140.86 -34.20 REMARK 500 PHE B 205 -125.39 65.34 REMARK 500 ILE B 206 -67.53 -99.82 REMARK 500 GLU B 296 135.60 -176.42 REMARK 500 TYR B 301 -161.04 -120.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CAA A 351 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CAA B 751 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 750 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1F0Y RELATED DB: PDB REMARK 900 L-3-HYDROXYACYL-COA DEHYDROGENASE COMPLEXED WITH ACETOACETYL-COA REMARK 900 AND NAD+ DBREF 1IL0 A 1 302 UNP Q16836 HCDH_HUMAN 7 308 DBREF 1IL0 B 1 302 UNP Q16836 HCDH_HUMAN 7 308 SEQADV 1IL0 GLN A 170 UNP Q16836 GLU 176 ENGINEERED MUTATION SEQADV 1IL0 GLN B 170 UNP Q16836 GLU 176 ENGINEERED MUTATION SEQRES 1 A 302 SER SER SER SER THR ALA SER ALA SER ALA LYS LYS ILE SEQRES 2 A 302 ILE VAL LYS HIS VAL THR VAL ILE GLY GLY GLY LEU MET SEQRES 3 A 302 GLY ALA GLY ILE ALA GLN VAL ALA ALA ALA THR GLY HIS SEQRES 4 A 302 THR VAL VAL LEU VAL ASP GLN THR GLU ASP ILE LEU ALA SEQRES 5 A 302 LYS SER LYS LYS GLY ILE GLU GLU SER LEU ARG LYS VAL SEQRES 6 A 302 ALA LYS LYS LYS PHE ALA GLU ASN PRO LYS ALA GLY ASP SEQRES 7 A 302 GLU PHE VAL GLU LYS THR LEU SER THR ILE ALA THR SER SEQRES 8 A 302 THR ASP ALA ALA SER VAL VAL HIS SER THR ASP LEU VAL SEQRES 9 A 302 VAL GLU ALA ILE VAL GLU ASN LEU LYS VAL LYS ASN GLU SEQRES 10 A 302 LEU PHE LYS ARG LEU ASP LYS PHE ALA ALA GLU HIS THR SEQRES 11 A 302 ILE PHE ALA SER ASN THR SER SER LEU GLN ILE THR SER SEQRES 12 A 302 ILE ALA ASN ALA THR THR ARG GLN ASP ARG PHE ALA GLY SEQRES 13 A 302 LEU HIS PHE PHE ASN PRO VAL PRO VAL MET LYS LEU VAL SEQRES 14 A 302 GLN VAL ILE LYS THR PRO MET THR SER GLN LYS THR PHE SEQRES 15 A 302 GLU SER LEU VAL ASP PHE SER LYS ALA LEU GLY LYS HIS SEQRES 16 A 302 PRO VAL SER CYS LYS ASP THR PRO GLY PHE ILE VAL ASN SEQRES 17 A 302 ARG LEU LEU VAL PRO TYR LEU MET GLU ALA ILE ARG LEU SEQRES 18 A 302 TYR GLU ARG GLY ASP ALA SER LYS GLU ASP ILE ASP THR SEQRES 19 A 302 ALA MET LYS LEU GLY ALA GLY TYR PRO MET GLY PRO PHE SEQRES 20 A 302 GLU LEU LEU ASP TYR VAL GLY LEU ASP THR THR LYS PHE SEQRES 21 A 302 ILE VAL ASP GLY TRP HIS GLU MET ASP ALA GLU ASN PRO SEQRES 22 A 302 LEU HIS GLN PRO SER PRO SER LEU ASN LYS LEU VAL ALA SEQRES 23 A 302 GLU ASN LYS PHE GLY LYS LYS THR GLY GLU GLY PHE TYR SEQRES 24 A 302 LYS TYR LYS SEQRES 1 B 302 SER SER SER SER THR ALA SER ALA SER ALA LYS LYS ILE SEQRES 2 B 302 ILE VAL LYS HIS VAL THR VAL ILE GLY GLY GLY LEU MET SEQRES 3 B 302 GLY ALA GLY ILE ALA GLN VAL ALA ALA ALA THR GLY HIS SEQRES 4 B 302 THR VAL VAL LEU VAL ASP GLN THR GLU ASP ILE LEU ALA SEQRES 5 B 302 LYS SER LYS LYS GLY ILE GLU GLU SER LEU ARG LYS VAL SEQRES 6 B 302 ALA LYS LYS LYS PHE ALA GLU ASN PRO LYS ALA GLY ASP SEQRES 7 B 302 GLU PHE VAL GLU LYS THR LEU SER THR ILE ALA THR SER SEQRES 8 B 302 THR ASP ALA ALA SER VAL VAL HIS SER THR ASP LEU VAL SEQRES 9 B 302 VAL GLU ALA ILE VAL GLU ASN LEU LYS VAL LYS ASN GLU SEQRES 10 B 302 LEU PHE LYS ARG LEU ASP LYS PHE ALA ALA GLU HIS THR SEQRES 11 B 302 ILE PHE ALA SER ASN THR SER SER LEU GLN ILE THR SER SEQRES 12 B 302 ILE ALA ASN ALA THR THR ARG GLN ASP ARG PHE ALA GLY SEQRES 13 B 302 LEU HIS PHE PHE ASN PRO VAL PRO VAL MET LYS LEU VAL SEQRES 14 B 302 GLN VAL ILE LYS THR PRO MET THR SER GLN LYS THR PHE SEQRES 15 B 302 GLU SER LEU VAL ASP PHE SER LYS ALA LEU GLY LYS HIS SEQRES 16 B 302 PRO VAL SER CYS LYS ASP THR PRO GLY PHE ILE VAL ASN SEQRES 17 B 302 ARG LEU LEU VAL PRO TYR LEU MET GLU ALA ILE ARG LEU SEQRES 18 B 302 TYR GLU ARG GLY ASP ALA SER LYS GLU ASP ILE ASP THR SEQRES 19 B 302 ALA MET LYS LEU GLY ALA GLY TYR PRO MET GLY PRO PHE SEQRES 20 B 302 GLU LEU LEU ASP TYR VAL GLY LEU ASP THR THR LYS PHE SEQRES 21 B 302 ILE VAL ASP GLY TRP HIS GLU MET ASP ALA GLU ASN PRO SEQRES 22 B 302 LEU HIS GLN PRO SER PRO SER LEU ASN LYS LEU VAL ALA SEQRES 23 B 302 GLU ASN LYS PHE GLY LYS LYS THR GLY GLU GLY PHE TYR SEQRES 24 B 302 LYS TYR LYS HET CAA A 351 54 HET NAD A 350 44 HET CAA B 751 54 HET NAD B 750 44 HETNAM CAA ACETOACETYL-COENZYME A HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE FORMUL 3 CAA 2(C25 H40 N7 O18 P3 S) FORMUL 4 NAD 2(C21 H27 N7 O14 P2) FORMUL 7 HOH *242(H2 O) HELIX 1 1 GLY A 24 THR A 37 1 14 HELIX 2 2 THR A 47 PHE A 70 1 24 HELIX 3 3 ASN A 73 THR A 87 1 15 HELIX 4 4 ASP A 93 VAL A 98 1 6 HELIX 5 5 HIS A 99 THR A 101 5 3 HELIX 6 6 ASN A 111 ALA A 126 1 16 HELIX 7 7 GLN A 140 ASN A 146 1 7 HELIX 8 8 ARG A 150 ASP A 152 5 3 HELIX 9 9 SER A 178 LEU A 192 1 15 HELIX 10 10 ILE A 206 ARG A 224 1 19 HELIX 11 11 SER A 228 GLY A 241 1 14 HELIX 12 12 GLY A 245 GLY A 254 1 10 HELIX 13 13 GLY A 254 MET A 268 1 15 HELIX 14 14 ASN A 272 GLN A 276 5 5 HELIX 15 15 SER A 278 GLU A 287 1 10 HELIX 16 16 GLY B 24 THR B 37 1 14 HELIX 17 17 THR B 47 PHE B 70 1 24 HELIX 18 18 ASN B 73 SER B 86 1 14 HELIX 19 19 ASP B 93 VAL B 97 5 5 HELIX 20 20 VAL B 97 THR B 101 5 5 HELIX 21 21 ASN B 111 ALA B 126 1 16 HELIX 22 22 GLN B 140 ASN B 146 1 7 HELIX 23 23 ARG B 150 ASP B 152 5 3 HELIX 24 24 SER B 178 LEU B 192 1 15 HELIX 25 25 ILE B 206 ARG B 224 1 19 HELIX 26 26 SER B 228 GLY B 241 1 14 HELIX 27 27 GLY B 245 GLY B 254 1 10 HELIX 28 28 GLY B 254 ASP B 269 1 16 HELIX 29 29 ASN B 272 GLN B 276 5 5 HELIX 30 30 SER B 278 GLU B 287 1 10 HELIX 31 31 LYS B 292 GLY B 295 5 4 SHEET 1 A 8 ILE A 88 SER A 91 0 SHEET 2 A 8 THR A 40 VAL A 44 1 O VAL A 41 N ALA A 89 SHEET 3 A 8 HIS A 17 ILE A 21 1 N VAL A 18 O THR A 40 SHEET 4 A 8 LEU A 103 GLU A 106 1 O LEU A 103 N THR A 19 SHEET 5 A 8 ILE A 131 SER A 134 1 O ILE A 131 N VAL A 104 SHEET 6 A 8 PHE A 154 HIS A 158 1 N ALA A 155 O PHE A 132 SHEET 7 A 8 LEU A 168 ILE A 172 -1 O GLN A 170 N HIS A 158 SHEET 8 A 8 HIS A 195 CYS A 199 1 O HIS A 195 N VAL A 169 SHEET 1 B 8 ILE B 88 SER B 91 0 SHEET 2 B 8 THR B 40 VAL B 44 1 O VAL B 41 N ALA B 89 SHEET 3 B 8 HIS B 17 ILE B 21 1 N VAL B 18 O THR B 40 SHEET 4 B 8 LEU B 103 GLU B 106 1 O LEU B 103 N THR B 19 SHEET 5 B 8 ILE B 131 SER B 134 1 O ILE B 131 N VAL B 104 SHEET 6 B 8 PHE B 154 PHE B 159 1 N ALA B 155 O PHE B 132 SHEET 7 B 8 LEU B 168 ILE B 172 -1 O GLN B 170 N HIS B 158 SHEET 8 B 8 HIS B 195 CYS B 199 1 O HIS B 195 N VAL B 169 CISPEP 1 ASN A 161 PRO A 162 0 -0.60 CISPEP 2 ASN B 161 PRO B 162 0 -0.07 SITE 1 AC1 18 SER A 61 LYS A 68 SER A 137 HIS A 158 SITE 2 AC1 18 PHE A 160 ASN A 161 VAL A 165 ASN A 208 SITE 3 AC1 18 LEU A 211 PRO A 243 MET A 244 LEU A 249 SITE 4 AC1 18 NAD A 350 HOH A 850 HOH A 956 GLY B 239 SITE 5 AC1 18 ALA B 240 HOH B 802 SITE 1 AC2 18 GLY A 239 ALA A 240 SER B 61 LYS B 68 SITE 2 AC2 18 SER B 137 HIS B 158 PHE B 160 ASN B 161 SITE 3 AC2 18 VAL B 165 ASN B 208 LEU B 211 PRO B 243 SITE 4 AC2 18 MET B 244 LEU B 249 NAD B 750 HOH B 804 SITE 5 AC2 18 HOH B1025 HOH B1027 SITE 1 AC3 21 GLY A 23 GLY A 24 LEU A 25 MET A 26 SITE 2 AC3 21 ASP A 45 GLN A 46 ALA A 107 ILE A 108 SITE 3 AC3 21 GLU A 110 LYS A 115 ASN A 135 SER A 137 SITE 4 AC3 21 PHE A 159 ASN A 161 VAL A 253 THR A 257 SITE 5 AC3 21 LYS A 293 CAA A 351 HOH A 809 HOH A 814 SITE 6 AC3 21 HOH A 872 SITE 1 AC4 27 GLY B 24 LEU B 25 MET B 26 ASP B 45 SITE 2 AC4 27 GLN B 46 ALA B 107 ILE B 108 GLU B 110 SITE 3 AC4 27 VAL B 114 LYS B 115 ASN B 135 SER B 137 SITE 4 AC4 27 HIS B 158 PHE B 159 ASN B 161 VAL B 253 SITE 5 AC4 27 THR B 257 LYS B 293 CAA B 751 HOH B 803 SITE 6 AC4 27 HOH B 815 HOH B 816 HOH B 840 HOH B 952 SITE 7 AC4 27 HOH B 998 HOH B1015 HOH B1041 CRYST1 49.657 87.719 158.395 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020138 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011400 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006313 0.00000 MASTER 325 0 4 31 16 0 23 6 0 0 0 48 END